SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001654954-18-013758
Filing Date
2018-12-10
Accepted
2018-12-10 14:10:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A cbmg_sc13ga.htm SC 13D/A 75044
  Complete submission text file 0001654954-18-013758.txt   76749
Mailing Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105 (408) 973-7884
Cellular Biomedicine Group, Inc. (Subject) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82437 | Film No.: 181225804
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 369 LUMO ROAD HONGSHAN DISTRICT WUHAN, HUBEI F4 430070
Business Address 369 LUMO ROAD HONGSHAN DISTRICT WUHAN, HUBEI F4 430070 86-027-87596552
Dangdal International Group Co. Ltd (Filed by) CIK: 0001678024 (see all company filings)

IRS No.: 000000000 | State of Incorp.: K3 | Fiscal Year End: 1231
Type: SC 13D/A